This paper documents dose-dependent effects of
ornithine aspartate (OA) on postprandial
hyperammonemia and plasma
amino acids. Ten patients with
cirrhosis were randomized to undergo 1 out of 4 infusion series. Each series consisted of four 8-h infusions (09:00 h-17:00 h), with placebo (NaCl), 5 g, 20 g or 40 g of OA being administered on separate days in varying sequences. This 4-fold crossover design was double-blind. On infusion days, patients received 2 oral
protein loads (0.25 g/kg at 09:00 h and 0.5 g/kg at 13:00 h). Venous blood samples were drawn every 2 h and the 24-h urine was collected. In addition to measuring plasma
ammonia and
amino acids, the
urea production rate, serum
glucose and serum
insulin were analyzed. A significant postprandial rise in the
ammonia concentration was noted during the infusions of placebo and 5 g of OA but did not occur with the dosages of 20 g (after the second
protein load) and 40 g (after both
protein loads). Furthermore, the latter dose, compared with placebo, significantly reduced plasma
ammonia after the minor
protein load.
Urea production rate increased when 20 g or 40 g of OA was administered. Of the
amino acids involved in the metabolic pathways of
ornithine and/or
aspartate,
glutamate showed a rise in its plasma level following infusion of 40 g of OA, whereas
glutamine did not. Concentrations of
methionine,
phenylalanine,
tyrosine,
threonine,
serine and
glycine declined progressively with increasing doses of OA (5-40 g). The highest dose of the
drug caused
hyperglycemia and
hyperinsulinemia.(ABSTRACT TRUNCATED AT 250 WORDS)